Treatment Options for Diffuse Midline Glioma (DMG/DIPG)

Learn about emerging treatments for DMG and DIPG. We’ve got it covered, from targeted therapy to cancer vaccines, gene therapy, steroids, drug combinations, and more.

Cancer Commons is truly unique at rapidly matching patients with advanced cancer with the best precision therapy or clinical trial.

E. David Crawford, MD
Cancer Commons Advisor

New Diffuse Midline Glioma (DMG/DIPG) Molecular Testing Options

Molecular testing helps match patients to the personalized treatments that are most likely to work for them. Keep up with new developments in molecular testing that could help guide DMG/DIPG treatment, such as tumor mutations and other biomarkers.

Precision oncology is very complicated and changes every day. The scientists of Cancer Commons provide rapid, compassionate, scientifically sound information about best options, a remarkable free service.

Razelle Kurzrock, MD
U.C. San Diego, CureMatch, Inc.

Living With Cancer

Cancer affects many aspects of life, whether you’re newly diagnosed, in the midst of treatment, or in follow-up care. Learn about ways to maintain quality of life, such as palliative care and managing side effects.

Patient Stories

You’re not alone. Read how other patients and caregivers navigated diagnosis, treatment, and life with cancer. We hope their stories provide insights and hope for your own cancer journey.

The Big Picture

Learn more about what’s new in advanced cancer research and treatment, including screening and statistics, using artificial intelligence to improve treatment, and other new horizons in cancer care.

Cancer and Covid-19

The coronavirus pandemic presents unprecedented challenges to cancer patients. We can help you understand how COVID-19 might impact your treatment and other aspects of your cancer care.